Study Identifies Protein Kinases as Potential Therapeutic Targets for Metastatic Prostate Cancer

Study Identifies Protein Kinases as Potential Therapeutic Targets for Metastatic Prostate Cancer
Researchers from the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have identified specific enzymes called protein kinases that participate in critical steps of bone and prostate cancer metastatic process, suggesting these kinases as potential therapeutic targets. The findings, which were published in the Proceedings of the National Academy of Sciences under the

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *